Windward Bio is a clinical-stage drug development company focused on creating treatments for severe respiratory conditions, including asthma and COPD, using long-acting monoclonal antibodies and bispecifics.

Leyden Labs develops non-vaccine intranasal antibody treatments to protect against respiratory viruses like influenza and coronaviruses.

Shanghai Matwings Technology Co., Ltd. specializes in AI-driven protein design, using its AccelProtein™ platform to predict protein functionality for applications in pharmaceuticals and synthetic biology.

AusperBio is a biotechnology company developing targeted oligonucleotide therapies for chronic hepatitis B and other chronic diseases.

LaNova Medicines is a biotech company specializing in antibody-drug conjugates (ADCs) and immuno-oncology, focusing on developing treatments like their anti-PD-1/VEGF bispecific antibody for cancer.

Account Labs is a Singapore-based company that offers a range of services in the blockchain and cryptocurrency industry, formed through the merger of UniPass and Keystone, and has raised $7.7 million in funding to expand its operations and develop its products and services.

Epigenic Therapeutics is a biotechnology company that develops gene editing therapies for various diseases using its proprietary technology platform, EPIREG, which optimizes CRISPR-Cas components for gene regulation without altering DNA sequences and employs a proprietary lipid nanoparticle medicine delivery system.